{"id":"https://openalex.org/W3161069647","doi":"https://doi.org/10.1016/j.jchromb.2021.122754","title":"A highly sensitive and selective UPLC-MS/MS assay for the determination of enarodustat (JTZ-951) in human plasma","display_name":"A highly sensitive and selective UPLC-MS/MS assay for the determination of enarodustat (JTZ-951) in human plasma","publication_year":2021,"publication_date":"2021-05-12","ids":{"openalex":"https://openalex.org/W3161069647","doi":"https://doi.org/10.1016/j.jchromb.2021.122754","mag":"3161069647","pmid":"https://pubmed.ncbi.nlm.nih.gov/34052557"},"language":"en","primary_location":{"id":"doi:10.1016/j.jchromb.2021.122754","doi":"https://doi.org/10.1016/j.jchromb.2021.122754","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jchromb.2021.122754","pdf_url":null,"source":{"id":"https://openalex.org/S103248676","display_name":"Journal of Chromatography B","issn_l":"1570-0232","issn":["1570-0232","1873-376X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chromatography B","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063284241","display_name":"Sudhakar M. Pai","orcid":"https://orcid.org/0000-0001-8091-546X","observed_orcids":["https://orcid.org/0000-0001-8091-546X"]},"institutions":[{"id":"https://openalex.org/I4405267189","display_name":"Akros Pharma Inc. (United States)","ror":"https://ror.org/01k528p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267189"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sudhakar Pai","raw_affiliation_strings":["Akros Pharma Inc., 302 Carnegie Center, Suite 300, Princeton, NJ 08540, USA. Electronic address: pai@akrospharma.com","Akros Pharma Inc., 302 Carnegie Center, Suite 300, Princeton, NJ 08540, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Akros Pharma Inc., 302 Carnegie Center, Suite 300, Princeton, NJ 08540, USA. Electronic address: pai@akrospharma.com","institution_ids":["https://openalex.org/I4405267189"]},{"raw_affiliation_string":"Akros Pharma Inc., 302 Carnegie Center, Suite 300, Princeton, NJ 08540, USA","institution_ids":["https://openalex.org/I4405267189"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060898621","display_name":"Mike Qingtao Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267189","display_name":"Akros Pharma Inc. (United States)","ror":"https://ror.org/01k528p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267189"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mike Qingtao Huang","raw_affiliation_strings":["Akros Pharma Inc., 302 Carnegie Center, Suite 300, Princeton, NJ 08540, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Akros Pharma Inc., 302 Carnegie Center, Suite 300, Princeton, NJ 08540, USA","institution_ids":["https://openalex.org/I4405267189"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Koichi Maki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108598","display_name":"Japan Tobacco (Japan)","ror":"https://ror.org/01xdq1k91","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210108598"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichi Maki","raw_affiliation_strings":["Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan","institution_ids":["https://openalex.org/I4210108598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042675325","display_name":"Michael P Waldron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296342797","display_name":"Pharmaceutical Product Development (United States)","ror":"https://ror.org/01sjx9496","country_code":"US","type":"company","lineage":["https://openalex.org/I1296342797"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Waldron","raw_affiliation_strings":["PPD Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PPD Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA","institution_ids":["https://openalex.org/I1296342797"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015583886","display_name":"Tomonori Yoshikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108598","display_name":"Japan Tobacco (Japan)","ror":"https://ror.org/01xdq1k91","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210108598"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomonori Yoshikawa","raw_affiliation_strings":["Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan","institution_ids":["https://openalex.org/I4210108598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103813678","display_name":"Tara Keller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296342797","display_name":"Pharmaceutical Product Development (United States)","ror":"https://ror.org/01sjx9496","country_code":"US","type":"company","lineage":["https://openalex.org/I1296342797"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tara Keller","raw_affiliation_strings":["PPD Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PPD Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA","institution_ids":["https://openalex.org/I1296342797"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062364763","display_name":"James Burnett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296342797","display_name":"Pharmaceutical Product Development (United States)","ror":"https://ror.org/01sjx9496","country_code":"US","type":"company","lineage":["https://openalex.org/I1296342797"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Burnett","raw_affiliation_strings":["PPD Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PPD Laboratories, 2244 Dabney Road, Richmond, VA 23230, USA","institution_ids":["https://openalex.org/I1296342797"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5063284241"],"corresponding_institution_ids":["https://openalex.org/I4405267189"],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":null,"fwci":0.4709,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.47107782,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"1176","issue":null,"first_page":"122754","last_page":"122754"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.7523999810218811,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.2401999980211258,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hif-prolyl-hydroxylase-inhibitors","display_name":"HIF prolyl hydroxylase inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.800000011920929},{"id":"https://openalex.org/keywords/human-plasma-quantitation","display_name":"human plasma quantitation","score":0.7820000052452087},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.7820000052452087},{"id":"https://openalex.org/keywords/isotope-labeled-internal-standards","display_name":"isotope-labeled internal standards","score":0.8529999852180481},{"id":"https://openalex.org/keywords/protein-precipitation-extraction","display_name":"protein precipitation extraction","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C137535248","wikidata":"https://www.wikidata.org/wiki/Q4914691","display_name":"Bioanalysis","level":2,"score":0.9396349787712097},{"id":"https://openalex.org/C74774607","wikidata":"https://www.wikidata.org/wiki/Q7251495","display_name":"Protein precipitation","level":3,"score":0.8861666917800903},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.8449690341949463},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8257725238800049},{"id":"https://openalex.org/C10390740","wikidata":"https://www.wikidata.org/wiki/Q2282401","display_name":"Analyte","level":2,"score":0.7288913726806641},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6117417216300964},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.5862665772438049},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.47053465247154236},{"id":"https://openalex.org/C23531484","wikidata":"https://www.wikidata.org/wiki/Q3196863","display_name":"Calibration curve","level":3,"score":0.45482686161994934},{"id":"https://openalex.org/C3020134792","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Human plasma","level":2,"score":0.4462182819843292},{"id":"https://openalex.org/C2778576202","wikidata":"https://www.wikidata.org/wiki/Q2540164","display_name":"Sample preparation","level":2,"score":0.4218497574329376},{"id":"https://openalex.org/C119128265","wikidata":"https://www.wikidata.org/wiki/Q900165","display_name":"Detection limit","level":2,"score":0.307743102312088},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.23933285474777222},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07770022749900818}],"mesh":[{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034442","descriptor_name":"N-substituted Glycines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D034442","descriptor_name":"N-substituted Glycines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D034442","descriptor_name":"N-substituted Glycines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jchromb.2021.122754","doi":"https://doi.org/10.1016/j.jchromb.2021.122754","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jchromb.2021.122754","pdf_url":null,"source":{"id":"https://openalex.org/S103248676","display_name":"Journal of Chromatography B","issn_l":"1570-0232","issn":["1570-0232","1873-376X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Chromatography B","raw_type":"journal-article"},{"id":"pmid:34052557","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34052557","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1967813249","https://openalex.org/W1980409192","https://openalex.org/W2004638171","https://openalex.org/W2007704948","https://openalex.org/W2009192569","https://openalex.org/W2016770221","https://openalex.org/W2032094362","https://openalex.org/W2052029582","https://openalex.org/W2113125823","https://openalex.org/W2128821627","https://openalex.org/W2148411671","https://openalex.org/W2152233370","https://openalex.org/W2768888006","https://openalex.org/W2998124187"],"related_works":["https://openalex.org/W4280568102","https://openalex.org/W4408419858","https://openalex.org/W4416564746","https://openalex.org/W3014491090","https://openalex.org/W3160527661","https://openalex.org/W4388539395","https://openalex.org/W2076105209","https://openalex.org/W7202117287","https://openalex.org/W4413194765","https://openalex.org/W4400236970"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-05-24T00:00:00"}